Daniel B. Soland
Insider Reports History
- Location
- Emeryville, CA
- Signature
- /s/ Jennifer J. Rhodes, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Daniel B. Soland:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACADIA PHARMACEUTICALS INC | Director | Common Stock | 44,041 | $768,075 | $17.44 | 29 May 2025 | Direct |
| ACADIA PHARMACEUTICALS INC | Director | Restricted Stock Units | 8,107 | $159,016 | $16.94 | 29 May 2025 | Direct |
| DBV Technologies S.A. | Director | Ordinary Shares | 20,000 | $34,800 | $1.74 | 01 Aug 2023 | Direct |
| IDERA PHARMACEUTICALS, INC. | CHIEF OPERATING OFFICER | Stock Option (Right to Buy) | 66,500 | 06 Jul 2022 | Direct | ||
| ACADIA PHARMACEUTICALS INC | Director | Director Stock Options (Right to Buy) | 13,793 | 29 May 2025 | Direct | ||
| KalVista Pharmaceuticals, Inc. | Director | Director Stock Option (Right to Buy) | 10,000 | 30 Sep 2021 | Direct |